Hinge Health files for US IPO as healthcare listings gain momentum
Hinge Health, which provides digital exercise therapy programs to help people manage and overcome muscle and joint pain, on Monday filed for its long-sought New York initial public offering.
Hinge Health just filed to go public. It could be the healthtech IPO the market has been waiting for.
Physical therapy startup Hinge Health just filed to go public. These are the most important takeaways from its S-1.
Virtual physical therapists Hinge Health files for IPO, estimated to raise $500M
Hinge Health, a 10-year-old company that offers a digital solution to treat chronic musculoskeletal (MSK) conditions, filed to go public. Although Hinge
Digital physical therapy provider Hinge Health files for IPO
Hinge Health uses software to help patients treat musculoskeletal injuries and chronic pain from the comfort of their homes. Hinge Health, a provider of digital physical therapy services, filed to go public on Monday,
Hinge Health Pursues IPO On High Revenue Growth
Hinge Health, Inc. targets a $326B market with innovative musculoskeletal care solutions. Click here to find out more about the upcoming HNGE stock IPO.
Hinge Health’s IPO Filing Follows Years of Inactivity In Digital Health
Hinge Health filed for an initial public offering on Monday, according to CNBC. Hinge Health provides software for remote musculoskeletal treatment and rehabilitation and reported higher revenue and a reduced net loss last year.
Morgan Stanley Target of Unusually Large Options Trading (NYSE:MS)
Morgan Stanley (NYSE:MS – Get Free Report) was the recipient of some unusual options trading on Monday. Stock investors purchased 40,803 put options on the company. This is an increase of 46% compared ...
J.P. Morgan economist sees 40% chance of a US recession in 2025
U.S. stocks have suffered their sharpest selloff in months as investors have grown nervous that Trump will slow the economy ...
Barclays to leverage investment banking, tech strengths to grow Asia-Pacific markets
Barclays plans to leverage its strength in investment banking and technology to prepare for a turbulent year ahead in the ...
Morgan Stanley Reaffirms Their Hold Rating on Moody’s (MCO)
In a report released today, Toni Kaplan from Morgan Stanley maintained a Hold rating on Moody’s (MCO – Research Report), with a price target of ...
Morgan Stanley Reiterates Overweight Rating for Jazz Pharmaceuticals (NASDAQ:JAZZ)
Morgan Stanley reaffirmed their overweight rating on shares of Jazz Pharmaceuticals (NASDAQ:JAZZ – Free Report) in a report ...
Yahoo Finance28d
Morgan Stanley Set to Sell $3 Billion of X Debt at No Discount
Morgan Stanley advised Musk on the purchase, led the financing and sales and also held the largest chunk of X debt. Other holders include Bank of America Corp., Barclays Plc, Mitsubishi UFJ ...